Related Experiment Video
Updated: Aug 29, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
[Relationship between protein tyrosine phosphorylation level and anoikis resistance of breast tumor cell lines]
Jiong Han1, Xin-Ping Liu, Li-Bo Yao
1Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R.China.
Background & Objectives:
Normal epithelial or endothelial cells can undergo anoikis, a type of apoptosis, when they are detached from their extracellular matrices (ECM), while most tumor cells derived from epithelial or endothelial tissues lose this feature. Most of the studies indicate that anoikis resistance of tumor cells is closely related to abnormal signal transductioin. The aim of this research was to screen out the tumor cell lines that are anoikis resistant, then to investigate the relationship between the protein tyrosine phosphorylation of signaling molecules and anoikis resistance feature of tumor cells.
Methods:
Anoikis resistance of breast tumor cell lines MCF-7, Bcap-37, and MDA-MB-231 was determined by DNA ladder assay, flow cytometry analysis, and soft agar assay upon suspending culture. A normal epithelial cell line MDCK (Madin-Darby canine kidney) was taken as a control. The inhibitory effect of genistein, a general protein tyrosine kinase inhibitor, on anoikis resistance of tumor cells was analyzed at the same time. The differences of total protein tyrosine phosphorylation levels between suspended and attached cultural conditions of three breast cancer cell lines were examined by Western blot analysis.
Results:
All the three tumor cell lines were distinctly anoikis resistant. Further study showed that these features could be suppressed by genistein. The results of Western blot analysis showed that the general level of tyrosine phosphorylation in suspended MDCK cells was decreased compared with that in attached cells, while tyrosine phosphorylation level of some proteins increased (more than 3.5-6.5 folds) aberrantly in suspended tumor cells.
Conclusion:
All the three breast tumor cells in this study are anoikis resistant respectively to some extent, and aberrant tyrosine phosphorylation of signaling proteins may play a role in the process of anoikis resistance of these tumor cells.
Insights
Tumor cells resist anoikis (apoptosis upon detachment) due to aberrant protein tyrosine phosphorylation. This study identified anoikis-resistant breast cancer cell lines and linked their survival to altered signaling pathways, suggesting potential therapeutic targets.
Area of Science:
- Cell Biology
- Cancer Research
- Molecular Oncology
Context:
- Normal cells undergo anoikis (apoptosis) when detached from the extracellular matrix (ECM).
- Tumor cells often evade anoikis, contributing to metastasis and treatment resistance.
- Abnormal signal transduction is implicated in anoikis resistance.
Purpose:
- To identify anoikis-resistant breast tumor cell lines.
- To investigate the relationship between protein tyrosine phosphorylation and anoikis resistance.
- To evaluate the effect of genistein, a tyrosine kinase inhibitor, on anoikis resistance.
Summary:
- Three breast cancer cell lines (MCF-7, Bcap-37, MDA-MB-231) demonstrated significant anoikis resistance.
- Genistein partially suppressed anoikis resistance in these tumor cells.
- Suspended tumor cells exhibited increased tyrosine phosphorylation of specific signaling proteins compared to attached cells and normal MDCK cells.
Impact:
- Aberrant protein tyrosine phosphorylation is a key factor in tumor cell anoikis resistance.
- Findings suggest that targeting tyrosine kinase signaling could be a therapeutic strategy for overcoming anoikis resistance in breast cancer.
- This research provides a foundation for further investigation into the molecular mechanisms driving anoikis resistance in cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
